Research Coverage of Japanese Listed Companies, Shared Research Inc

Shared Research

Research Coverage of Japanese Listed Companies

Shared Research Inc

Pioneering research coverage of Japanese listed companies. Now customizable and interactive for global institutional investors. Corporate access reimagined.

Equity Bottom-Up

<ul><li>Revenue increased to JPY457.1bn (+8.2% YoY) with operating profit at JPY22.6bn (+11.9% YoY), driven by store expansions.</li><li>The company opened 40 drugstores and 37 dispensing pharmacies, closing five, enhancing area dominance and healthcare support.</li><li>For FY05/26, revenue forecasted to grow 7.5% YoY, with a dividend of JPY90 per share, payout ratio 35.7%.</li></ul>

Revenue increased to JPY457.1bn (+8.2% YoY) with operating profit at JPY22.6bn (+11.9% YoY), driven by store expansions.The company opened 40 drugstores and 37 dispensing pharmacies, closing five, enhancing area dominance and healthcare support.For FY05/26, revenue forecasted to grow 7.5% YoY, with a dividend of JPY90 per share, payout ratio 35.7%.

Create Sd Holdings Co (3148 JP): Full-year FY05/25 flash update

<ul><li>Revenue increased by 8.4% YoY to JPY339.5bn, with gross profit rising 7.6% YoY to JPY88.1bn.</li><li>Operating profit grew 5.4% YoY to JPY16.4bn, supported by revenue growth and cost control measures.</li><li>Net income attributable to owners rose 4.4% YoY to JPY11.2bn, despite intensified price competition and market challenges.</li></ul>

Revenue increased by 8.4% YoY to JPY339.5bn, with gross profit rising 7.6% YoY to JPY88.1bn.Operating profit grew 5.4% YoY to JPY16.4bn, supported by revenue growth and cost control measures.Net income attributable to owners rose 4.4% YoY to JPY11.2bn, despite intensified price competition and market challenges.

Create Sd Holdings Co (3148 JP): Q3 FY05/25 flash update

<ul><li>Revenue increased to JPY224.8bn (+8.4% YoY), with gross profit at JPY58.2bn (+7.9% YoY) and operating profit at JPY10.5bn (+6.2% YoY).</li><li>The company opened 23 drugstores and 15 in-store dispensing pharmacies, while closing two stores, enhancing operational capacity.</li><li>Environmental management initiatives included installing solar panels and starting operations at a new logistics center.</li></ul>

Revenue increased to JPY224.8bn (+8.4% YoY), with gross profit at JPY58.2bn (+7.9% YoY) and operating profit at JPY10.5bn (+6.2% YoY).The company opened 23 drugstores and 15 in-store dispensing pharmacies, while closing two stores, enhancing operational capacity.Environmental management initiatives included installing solar panels and starting operations at a new logistics center.

Create Sd Holdings Co (3148 JP): 1H FY05/25 flash update

<ul><li>Revenue increased by 9.4% YoY to JPY113.9bn, with growth in comparable store revenue and customer count.</li><li>Operating profit rose by 10.7% YoY to JPY5.3bn, supported by higher gross profit and cost control measures.</li><li>The company expanded its network by opening 10 drugstores and six in-store dispensing pharmacies, closing one store.</li></ul>

Revenue increased by 9.4% YoY to JPY113.9bn, with growth in comparable store revenue and customer count.Operating profit rose by 10.7% YoY to JPY5.3bn, supported by higher gross profit and cost control measures.The company expanded its network by opening 10 drugstores and six in-store dispensing pharmacies, closing one store.

Create Sd Holdings Co (3148 JP): Q1 FY05/25 flash update

Asia Pac IPO & Placement Research, China biotech, Aequitas Research

Ke Yan, CFA, FRM

Asia Pac IPO & Placement Research, China biotech

IPOs and Placements coverage across Asia Pacific

Aequitas Research

We cover all listing across the Asia Pacific along with follow-up placements. As of Dec 2020, our team had covered 539 IPOs with a hit rate of 73.5% and 685 placements with a hit rate of 66.8%.

We combine fundamental bottom-up views with our proprietary quantitative framework to provide a holistic coverage across new listings and placements. Our coverage includes pre-IPO notes before the deal is launched, follow-up analysis once the deal is live and post-listing trading analysis as well.

Quantitative Analysis

<ul>
<li>We analyzed the changes in margin trading positions of JPX stocks as of May 30th. The aggregated net margin trading position is USD17,220m.</li>
<li>We tabulate league tables for top/bottom net long/short of margin trading by value, net margin buy as multiple of ADT.</li>
<li>We highlight net margin buy/sell changes in Kawasaki Heavy Industries, Mitsubishi Ufj Financial, Disco, Hitachi, Toyota Industries, Skylark, Toyota Motor, Sanrio, Ihi, Create Sd.</li>
</ul>


We analyzed the changes in margin trading positions of JPX stocks as of May 30th. The aggregated net margin trading position is USD17,220m.
We tabulate league tables for top/bottom net long/short of margin trading by value, net margin buy as multiple of ADT.
We highlight net margin buy/sell changes in Kawasaki Heavy Industries, Mitsubishi Ufj Financial, Disco, Hitachi, Toyota Industries, Skylark, Toyota Motor, Sanrio, Ihi, Create Sd.


JPX Margin Trading Weekly (May 30th): Kawasaki Heavy Industries, Mitsubishi Ufj Financial, Disco

Japan

CREATE SD HOLDINGS Co Ltd operates a chain of drug stores based in Kanagawa. The Company sells medical supplies, cosmetics, foodstuff, baby products and daily goods. CREATE SD HOLDINGS also sells prescription medicine.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Create Sd Holdings Co (3148 JP)